Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Rapid Dose Therapeutics Corp
C.DOSE
Alternate Symbol(s):
RDTCF
Cannabis
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into...
the bloodstream, resulting in rapid onset of the active ingredient. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The Company also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DOSE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Comment by
bajanjohn
on Feb 07, 2023 2:17pm
RE:Why are we not trading yet?????
Are there problems or are they about to make a major announcement before thay start trading?
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Feb 06, 2023 8:18pm
Why are we not trading yet?????
Are there still problems???
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Feb 03, 2023 8:03pm
RE:RE:Additional revenue?
The sad reality is there is really no market. Therefore predicable sales given that reality. No way to fix this you can't buy cash forever and there is no real market unfortunately fot this
...more
(6)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Feb 03, 2023 7:46pm
RE:Additional revenue?
This is going nowhere. Incompetent management can't even keep the books Just take the hit and get out Now. This is nor groundbreaking tech, lots of better options.
(1937)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 02, 2023 9:27pm
RE:Additional revenue?
I got no answer from IR so am assuming the nutraceutical revenue is small.... Hello, The financials do not breakout revenue from cannabis strips and nutraceutical strips. What is the split
...more
(4)
•••
Profiteer
X
View Profile
View Bullboard History
Post by
Profiteer
on Feb 02, 2023 8:12pm
Additional revenue?
I walked into an ESSO station and there they were strategically placed: Quickstrip Melatonin & Energy. Naturally I had to buy some to bump up the share price. Lol. I believe this is part of the
...more
(1937)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 02, 2023 1:25pm
RE:Financials in ....where do we go?
The only thing generating revenue is cannabis strips so maybe do some channel checks on products offered by the 3 customers. Thrive The Company produces CBD and THC QuickStrip™ products for Thrive
...more
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Comment by
Luckierjack2
on Feb 02, 2023 1:04pm
RE:Financials in ....where do we go?
Looking at the financials, they have $638k of current assets and debts of about $4 million. Probably going to 4 of 5 cents. Interesting technology, but who knows what went wrong.
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Feb 02, 2023 1:00pm
Financials in ....where do we go?
Ok... so now is the time for all the experts out there to share their thoughts on wher the share price will go once we start trading
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Comment by
Luckierjack2
on Feb 01, 2023 5:45pm
RE:When do we start trading again?
When they trade is based upon if there are other issues with IIROC. It will be announced pre trading day.
(5)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Feb 01, 2023 1:46pm
When do we start trading again?
I defer to all that are more knowledgable then me, as to when we can expect to be trading again, Also will it be announced before a trading session or mid session.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 01, 2023 12:20pm
New Press Release - Rapid Dose Therapeutics Reports Quarterly Financial Results for First Three Quarters of the 2023 Fiscal Year
Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year. Now that the Company has completed the filing of its audited financial statements for the fiscal year ended February 28, 2022 as well as its...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 01, 2023 12:17pm
New Press Release - Rapid Dose Therapeutics Reports Fiscal Year 2022 Financial Results
On Friday, January 27, 2023, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), filed its financial results for the fiscal year ended February 28, 2022. Now that the Company has completed the filing of its audited financial statements for the fiscal year ended February 28, 2022...
read article.
(1937)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 30, 2023 11:41am
RE:Fins on sedar
May and Nov qtrs posted this am Q ending Revenue Gross profit Margin Nov 22
...more
(1937)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jan 30, 2023 11:34am
Fins on sedar
On October 10 2020, the Company received its site licence for Natural Health Products approved for manufacturing, packaging and labelling of natural health products. Importing, under that Licence
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims